Retinal Neuro-vascular Coupling in Patients With Multiple Sclerosis

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Multiple Sclerosis, Relapsing-RemittingOptic Neuritis
Interventions
DEVICE

Dynamic Vessel Analyzer (DVA)

Retinal vessel diameters and oxygen saturation will be measured with the DVA device.

DEVICE

Fourier Domain Doppler Optical Coherence Tomography (FDOCT)

Retinal blood flow will be assessed using FDOCT.

DEVICE

Optical coherence tomography (OCT)

Nerve fiber layer thickness and central retinal thickness will be measured using OCT.

DEVICE

Optical coherence tomography angiography (OCTA)

Retinal microvasculature will be assessed using OCTA.

Trial Locations (1)

1090

RECRUITING

Department of Clinical Pharmacology, Medical University of Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER